Dianthus Therapeutics

DNTH

Valor de mercado US$ 4,84 bi

#	Nome	Posição	Valor negociado	Ações Variação	Variação na participação
1	1 TRV GP IV Boston, Massachusetts	US$ 8,11 mi	–	–	–
2	2 Deep Track Capital Greenwich, Connecticut	US$ 6,43 mi	–	–	–
3	3 Atlas Venture Life Science Advisors Cambridge, Massachusetts	US$ 4,17 mi	–	–	–
4	4 Alphabet Inc Mountain View, California	US$ 4,01 mi	–	–	–
5	5 Janus Henderson Group London,	US$ 3,57 mi	+US$ 1,68 mi	+68.066	+57%
6	6 Casdin Capital New York	US$ 2,9 mi	-US$ 554 mil	-22.404	-13%
7	7 OrbiMed New York	US$ 2,7 mi	–	–	–
8	8 TCG Crossover Management Palo Alto, California	US$ 2,55 mi	–	–	–
9	9 Vanguard Group Malvern, Pennsylvania	US$ 2,29 mi	+US$ 74,2 mil	+3.003	+3%
10	10 Millennium Management New York	US$ 2,25 mi	+US$ 728 mil	+29.474	+34%
11	11 Wellington Management Group Boston, Massachusetts	US$ 1,55 mi	-US$ 15,2 mil	-616	-0,8%
12	12 Great Point Partners Greenwich, Connecticut	US$ 1,4 mi	–	–	–
13	13 Woodline Partners San Francisco, California	US$ 1,12 mi	+US$ 211 mil	+8.545	+17%
14	14 BlackRock New York	US$ 955 mil	-US$ 2,07 mi	-83.859	-63%
15	15 Gilder Gagnon Howe & Co New York	US$ 895 mil	-US$ 4,07 mi	-164.867	-78%
16	16 Renaissance Technologies New York	US$ 878 mil	+US$ 760 mil	+30.755	+206%
17	17 Adage Capital Partners Boston, Massachusetts	US$ 847 mil	+US$ 491 mil	+19.879	+82%
18	18 Laurion Capital Management New York	US$ 699 mil	+US$ 900 mil	+36.394	Nova
19	19 Bleichroeder LP New York	US$ 581 mil	–	–	–
20	20 JP Morgan Chase New York	US$ 555 mil	+US$ 29,2 mil	+1.183	+4%
21	21 Palo Alto Investors Palo Alto, California	US$ 519 mil	–	–	–
22	22 RBF Capital San Francisco, California	US$ 446 mil	+US$ 574 mil	+23.214	Nova
23	23 Two Sigma Advisers New York	US$ 444 mil	+US$ 210 mil	+8.488	+58%
24	24 Geode Capital Management Boston, Massachusetts	US$ 412 mil	-US$ 385 mil	-15.589	-42%
25	25 Harvard Management Company Boston, Massachusetts	US$ 399 mil	–	–	–

Dianthus Therapeutics DNTH Valor de mercado US$ 4,84 bi

Dianthus Therapeutics

DNTH

Valor de mercado US$ 4,84 bi